Finland· FI-REL-REL58534

Genvoya

A emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat product containing elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide, registered in Finland by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR18

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedGenvoyaATCJ05AR18REGISTER NO.FI-REL-REL58534PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR18 (emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat · ATC J05AR18

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir alafenamide
Manufacturer
Gilead Sciences Ireland UC
Country
Finland (FI)
ATC code
J05AR18
ATC class
Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Genvoya
  • Liechtenstein · Genvoya
  • Norway · Genvoya

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c94e1ec8-ff50-4004-9f89-9a8b21cd4582
GET /v1/drugs/c94e1ec8-ff50-4004-9f89-9a8b21cd4582?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1.67",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "ED",
  "strength": "90 mg / 90 mg / 120 mg / 6 mg",
  "atc_label": "emtrisitabiini, tenofoviirialafenamidi, elvitegraviiri ja kobisistaatti",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/15/1061/003-004",
  "fimea_rel_id": "REL58534",
  "authorised_at": "2022-10-03"
}

See everything about emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.